S&P/ASX All Ords Index (ASX: XAO) shares are 1% higher at 8,741 points on Tuesday.
Today, 307 ASX shares are rising, 48 are steady, and 145 are falling.
Among the fallers are these four companies that have hit 52-week low share prices today.
Are they a buy, hold, or sell?
Let's ask the experts.
Image source: Getty Images
Fletcher Building Ltd (ASX: FBU)
The Fletcher Building share price fell to a 52-week low of $2.42 on Tuesday.
This ASX industrials share is down 21% in the year to date (YTD), and down 17% over the past 12 months.
On The Bull this week, Blake Halligan from Catapult Wealth revealed a sell rating on the building materials and services provider.
He said the 1H FY26 report "highlighted ongoing pressure", with net debt remaining elevated and the company cutting capital expenditure.
Halligan said:
Earnings before interest and tax from continuing operations before significant items was $NZ145 million, which was marginally below expectations. The company has announced the sale of its construction division for $NZ315.6 million.
However, broader conditions in New Zealand remain subdued, and a meaningful earnings recovery isn't expected until calendar year 2027. With limited catalysts and no dividend support, better opportunities present elsewhere.
Guzman Y Gomez Ltd (ASX: GYG)
The Guzman Y Gomez share price sank to a record low of $15.48 in earlier trading.
The ASX consumer discretionary share has fallen 26% YTD and tumbled 50% over 12 months.
Morgans has a buy rating on the stock but recently slashed its 12-month price target from $32.30 to $24.
The broker said:
If it was just about Australia, GYG would be doing just fine right now. But it's not just about Australia.
Unfortunately, the pace of network expansion in the US so far has been pedestrian and the restaurants it has opened have lost more money than expected.
GYG has a bit to prove, but we can be certain it is going to give it all it's got to ultimately realise its growth ambitions.
Endeavour Group Ltd (ASX: EDV)
The Endeavour share price fell to a record low of $3.28 today.
Endeavour shares have declined 10% YTD and have fallen 14% over the past 12 months.
Last week, Citi downgraded the ASX consumer staples share to a hold rating.
The broker also reduced its 12-month price target from $4.30 to $3.70.
Healius Ltd (ASX: HLS)
The Healius share price dropped to a record low of 52 cents today.
This ASX healthcare share has crashed 42% in the YTD and 63% over 12 months.
Healius is one of many ASX healthcare shares trading at multi-year lows today.
The sector is facing multiple headwinds due to currency shifts, US tariffs, and higher labour costs and other expenses.
Healius, a pathology services provider, reported improved financial metrics but continuing losses overall in its 1H FY26 report.
The company reported an underlying loss of $11 million for 1H FY26, which was an improvement on its $20.2 million loss for 1H FY25.
Morgans has a hold rating on Healius shares with a 12-month target of 80 cents.
The broker commented:
While management maintained FY26 earnings in line with consensus and operational discipline is improving, sustainable earnings leverage remains an open question and dependent on execution.
